On the recordMarch 30, 2023
What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?
Source
congress.govEditor's note · Context
Wyden seeks recommendations for improving transparency in drug pricing.
Share
More from Ron Wyden
Aug 1, 2026
More importantly, independent privacy and security oversight is not an optional expense to be cut when it becomes inconvenient.
Aug 26, 2026
We strongly urge BLM to reject this proposed rescission and maintain the 2024 Waste Prevention rule.
Aug 19, 2026
Each person whose information was inappropriately disclosed is entitled to know what happened to it, and Congress is entitled to know how a federal agency came to violate the same court order three times in six months.
Aug 18, 2026
extremely dangerous to give Trump massive new tariff powers, particularly after we've seen the disastrous impacts of his corrupt, chaotic, and inflationary tariff spree,"
Other voices in this conversation
